In the case of RA, mobilizing RA as such (e.g., by bringing systemic inflammation under control) might decrease the risk of LOAD, and the investigation of lysosomal pathways (e.g., cathepsin D modulation) may provide protection against PD [11,12]. The gene discussed is CTSD; the disease is rheumatoid arthritis.